The FDA Funding Crisis.

Area of Science:

• Public Health Policy
• Regulatory Science
• Pharmaceutical Economics

Background:

• The Food and Drug Administration (FDA) is responsible for ensuring the safety of drugs, supplements, and the food supply, a significant portion of US consumer spending.
• Current FDA responsibilities are expanding due to increased monitoring of imported products, drug shortages, and compounding pharmacies.

Purpose of the Study:

• To evaluate the adequacy of current Food and Drug Administration (FDA) funding in light of its expanding regulatory and oversight responsibilities.
• To highlight the necessity for increased financial resources to maintain the FDA's effectiveness in safeguarding public health.

Main Methods:

• Analysis of FDA's mandated responsibilities and operational scope.
• Assessment of current funding levels against increasing workload demands.
• Review of potential funding sources, including federal appropriations and industry fees.

Main Results:

• The FDA's existing funding is questioned due to a growing list of critical oversight areas.
• Increased responsibilities, including monitoring imported goods and drug shortages, strain current resources.
• Scientific advancements and new legislation further escalate the FDA's workload.

Conclusions:

• Current FDA funding levels are inadequate to meet escalating responsibilities and maintain operational status quo.
• Equitable increases in funding from federal sources and industry fees are essential for the FDA.
• Sustained budget increases are necessary to align with scientific progress, legislative changes, and industry growth to ensure public safety.